A Study of INCMGA00012 in Participants With Selected Solid Tumors (POD1UM-203)

Conditions:   Metastatic Non-small Cell Lung Cancer;   Locally Advanced Urothelial Cancer;   Metastatic Urothelial Cancer;   Unresectable Melanoma;   Metastatic Melanoma;   Locally Advanced Renal Cell Carcinoma;   Metastatic Clear-Cell Renal Cell Carcinoma Intervention:   Drug: INCMGA00012 Sponsor:   Incyte Corporation Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials